These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8404750

  • 1. Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients?
    McKee PJ, Blacklaw J, Friel E, Thompson GG, Gillham RA, Brodie MJ.
    Epilepsia; 1993; 34(5):937-43. PubMed ID: 8404750
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study.
    Dalla Bernardina B, Fontana E, Vigevano F, Fusco L, Torelli D, Galeone D, Buti D, Cianchetti C, Gnanasakthy A, Iudice A.
    Epilepsia; 1995 Jul; 36(7):687-91. PubMed ID: 7555986
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 4. Vigabatrin withdrawal randomized study in children.
    Chiron C, Dulac O, Gram L.
    Epilepsy Res; 1996 Nov; 25(3):209-15. PubMed ID: 8956918
    [Abstract] [Full Text] [Related]

  • 5. Gamma-vinyl GABA (vigabatrin) and mood disturbances.
    Aldenkamp AP, Vermeulen J, Mulder OG, Overweg J, Van Parys JA, Beun AM, Van 't Slot B.
    Epilepsia; 1994 Nov; 35(5):999-1004. PubMed ID: 7925172
    [Abstract] [Full Text] [Related]

  • 6. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R, Herranz JL, Valdizán EM, Armijo JA.
    Epilepsia; 1992 Nov; 33(5):923-31. PubMed ID: 1396437
    [Abstract] [Full Text] [Related]

  • 7. Vigabatrin: clinical evidence supporting rational polytherapy in management of uncontrolled seizures.
    de Bittencourt PR, Mazer S, Marcourakis T, Bigarella MM, Ferreira ZS, Mumford JP.
    Epilepsia; 1994 Nov; 35(2):373-80. PubMed ID: 8156960
    [Abstract] [Full Text] [Related]

  • 8. Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy. The Canadian Vigabatrin Study Group.
    Guberman A, Bruni J.
    Seizure; 2000 Mar; 9(2):112-8. PubMed ID: 10845734
    [Abstract] [Full Text] [Related]

  • 9. Dose-Response Study of Vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures.
    Dean C, Mosier M, Penry K.
    Epilepsia; 1999 Jan; 40(1):74-82. PubMed ID: 9924905
    [Abstract] [Full Text] [Related]

  • 10. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.
    Bruni J, Guberman A, Vachon L, Desforges C.
    Seizure; 2000 Apr; 9(3):224-32. PubMed ID: 10777431
    [Abstract] [Full Text] [Related]

  • 11. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA, Dumas C, Ghirardi L.
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [Abstract] [Full Text] [Related]

  • 12. Vigabatrin: rational treatment for chronic epilepsy.
    Ring HA, Heller AJ, Farr IN, Reynolds EH.
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1051-5. PubMed ID: 2292696
    [Abstract] [Full Text] [Related]

  • 13. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin.
    Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856
    [Abstract] [Full Text] [Related]

  • 14. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy.
    Dodrill CB, Arnett JL, Sommerville KW, Sussman NM.
    Epilepsia; 1995 Feb; 36(2):164-73. PubMed ID: 7821274
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy.
    Loiseau P, Hardenberg JP, Pestre M, Guyot M, Schechter PJ, Tell GP.
    Epilepsia; 1986 Feb; 27(2):115-20. PubMed ID: 3514204
    [Abstract] [Full Text] [Related]

  • 16. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy.
    Rimmer EM, Richens A.
    Lancet; 1984 Jan 28; 1(8370):189-90. PubMed ID: 6141335
    [Abstract] [Full Text] [Related]

  • 17. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.
    Brodie MJ, Mumford JP.
    Epilepsy Res; 1999 Apr 28; 34(2-3):199-205. PubMed ID: 10210035
    [Abstract] [Full Text] [Related]

  • 18. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S.
    Epilepsia; 2014 Jan 28; 55(1):57-66. PubMed ID: 24446953
    [Abstract] [Full Text] [Related]

  • 19. Double-blind dose reduction study of vigabatrin in complex partial epilepsy.
    Sivenius MR, Ylinen A, Murros K, Matilainen R, Riekkinen P.
    Epilepsia; 1987 Jan 28; 28(6):688-92. PubMed ID: 3319536
    [Abstract] [Full Text] [Related]

  • 20. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
    Spanaki MV, Siegel H, Kopylev L, Fazilat S, Dean A, Liow K, Ben-Menachem E, Gaillard WD, Theodore WH.
    Neurology; 1999 Oct 22; 53(7):1518-22. PubMed ID: 10534261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.